GlaxoSmithKline announces strategic automation partner
15 September 2015
Siemens and GlaxoSmithKline have entered a global strategic partnership which will see Siemens become a strategic partner of GSK in manufacturing automation and the preferred automation supplier for its production and R&D sites worldwide, including Vaccines.
This latest agreement further develops an already long standing relationship between the companies and helps GSK to refresh their global automation strategy. Dave Tudor, vice president Primary Supply and leader of the Global Automation Steering Team of GSK, said: “One of our objectives is to simplify and standardise the automation space by identifying a small number of systems and suppliers and this is the first step on our journey to achieving this.”
Eckard Eberle, CEO of the Siemens Business Unit Process Automation, added: “Integrated automation and digitalisation solutions are important levers for pharmaceutical companies to raise efficiency and productivity while ensuring safety and quality… we will support GSK by providing a unique integrated portfolio comprising hardware, software and services across the entire plant life cycle.”
The partnership will provide a focus into process control, equipment control and building management systems within the manufacturing and R&D pilot plants of GlaxoSmithKline. Four main areas have been identified – Modular Manufacturing, Batch Sterile Facility Blue Print, Machine and Production Line Optimisation and Manufacturing Blue Print for different Dosage forms.
Contact Details and Archive...
Most Viewed Articles...